Related Experiment Video
Updated: Jun 22, 2025
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Management of circumscribed choroidal hemangioma at a tertiary care center
İrem Koç1, Aysun Yücel Gençoğlu2, Burcu Yücekul3
1Ocular Oncology Service, Department of Ophthalmology, Hacettepe University School of Medicine, Ankara, Turkey. irem.koc@hacettepe.edu.tr.
Insights
Transpupillary thermotherapy (TTT) offers effective anatomical outcomes for circumscribed choroidal hemangioma (CCH). This review highlights various CCH management strategies and potential vascular implications in fellow eyes.
Area of Science:
- Ophthalmology
- Medical Research
Background:
- Circumscribed choroidal hemangioma (CCH) is a rare vascular tumor.
- Understanding long-term outcomes is crucial for patient management.
Purpose of the Study:
- To review long-term outcomes of circumscribed choroidal hemangioma (CCH).
- Evaluate the effectiveness of different treatment modalities for CCH.
Main Methods:
- Retrospective review of hospital charts for CCH cases diagnosed between 2008 and 2019.
- Analysis of management strategies including observation, transpupillary thermotherapy, laser photocoagulation, photodynamic therapy, brachytherapy, and radiosurgery.
- Assessment of anatomical outcomes and optical coherence tomography angiography findings.
Main Results:
- 172 patients were managed with various treatments; transpupillary thermotherapy (52.9%) and observation (30.2%) were most common.
- Stable anatomical outcomes were observed in 87.1% of the observation group.
- Improved anatomical outcomes were achieved in 60.5% of the transpupillary thermotherapy group.
- Optical coherence tomography angiography revealed vascular density differences in fellow eyes.
Conclusions:
- Circumscribed choroidal hemangioma (CCH) can be managed effectively with multiple treatment options.
- Transpupillary thermotherapy demonstrates anatomical efficacy in select CCH cases.
- CCH diagnosis may indicate underlying vascular changes in the fellow eye.
Purpose:
To review long-term outcomes of circumscribed choroidal hemangioma (CCH).
Methods:
Hospital charts of all CCH cases diagnosed from 2008 to 2019 were retrospectively reviewed.
Results:
All 172 patients were managed with either observation, transpupillary thermotherapy, argon laser photocoagulation, photodynamic therapy, plaque brachytherapy or stereotactic radiosurgery. The most common 3 modes of management were clinical observation (30.2%), transpupillary thermotherapy (52.9%) and argon laser photocoagulation (8.7%). Median follow-up time was 10 months (range: 3, 160). Anatomical outcomes were stable in 87.1% of observation group and improved in 60.5% of thermotherapy group. Quantified optical coherence tomography angiography findings showed statistical differences in vascular and perfusion densities in fellow eyes of hemangioma patients.
Conclusion:
Circumscribed choroidal hemangioma can be treated in various ways. Transpupillary thermotherapy is an anatomically effective treatment in selected cases. The diagnosis of CCH may have vascular implications in fellow eyes of the patients.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...